Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. marsi

MARSI SIGNED

Disruptive technologies for effectively rehabilitating chronic ambulatory disability

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 MARSI project word cloud

Explore the words cloud of the MARSI project. It provides you a very rough idea of what is the project "MARSI" about.

lifestyle    acquiring    mobility    functional    share    36m    commercialized    limited    minimal    physical    walking    device    elders    strength    losing    nervous    avoiding    14    expectancy    spina    joining    house    progressive    synchronized    certification    enlarge    disability    function    orthoses    jobs    sum    motor    programs    injury    alliance    powered    disabled    remaining    worlwide    lower    spinal    everyday    musculoskeletal    diseases    turnover    critical    psychosocial    sessions    expensive    muscle    marsi    ares    joints    rehabilitation    neurological    bionics    minimize    paraplegia    therapeutic    complications    cerebral    restore    physically    ambulatory    quality    cord    2023    difficulty    market    time    company    disorders    renting    showing    active    health    million    escribano    week    frame    industrial    overcome    models    15    patients    weakness    effortlessly    disorder    min    81    daily    speed    autonomy    life    portfolio    roughly    industrialization    covers    dementia    barrier    treatments    safely    bifida    sme    quadriplegia    muscles    walk    stroke    correspond    neuromuscular    impedes    people    palsy    medicines   

Project "MARSI" data sheet

The following table provides information about the project.

Coordinator		 MARSI BIONICS SL 

Organization address
address: CALLE RUE DEL PERCEBE 30
city: RIVAS VACIAMADRID
postcode: 28521
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Spain [ES]
 Project website http://www.marsibionics.com/
 Total cost 2˙499˙150 €
 EC max contribution 1˙640˙730 € (66%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-03-01   to  2020-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MARSI BIONICS SL ES (RIVAS VACIAMADRID) coordinator 1˙640˙730.00

Map

 Project objective

Worlwide, about 60 million people have some kind of difficulty in walking, which is related to some neurological disorder (stroke, dementia, neuromuscular diseases, etc). Roughly 40 million of affected correspond to elders and the % is higher in Europe. The remaining is the sum of physically disabled by cerebral palsy (14 million), neuromuscular diseases (4 million), spinal cord injury (paraplegia and quadriplegia, 3 million) and spina bifida (3 million). Neurological disorders affect the lower motor of the nervous system and share the progressive muscle weakness, which lead to several walk disability, loss of autonomy and psychosocial consequences. Most therapeutic treatments are limited to medicines and musculoskeletal rehabilitation programs, which are very expensive and limited to 15-30 min/week rehabilitation sessions. Active lifestyle is the most effective measure to restore the physical conditions. But the loss of muscle strength impedes the ambulatory function. The need is for a device allowing them walking effortlessly and safely in the everyday life activities. Based on our ARES technology, -the minimal functional unit providing synchronized joints-muscles mobility- Marsi Bionics has developed powered orthoses for in-house rehabilitation of patients affected by muscle weakness disorders, showing a product portfolio that covers the needs of a wide range of Neurological Disorders. Marsi products will be commercialized under renting models allowing patients acquiring it for daily use. This technology will improve these patients life quality and enlarge life expectancy by avoiding critical health complications of losing walking ability. Marsi is strengthened by joining with a leading company in the current industrial market, ESCRIBANO. This alliance in the frame of SME Phase 2 will speed up industrialization, overcome the certification barrier and minimize the time to market. As a result, we expect to reach above 36M€ turnover in 2023 and 81 generated jobs.

 Deliverables

List of deliverables.
Dissemination and Communication continuous monitoring (actions, results, congresses, materials and KPI. Documents, reports 2020-03-04 09:47:52

Take a look to the deliverables list in detail:  detailed list of MARSI deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MARSI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MARSI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More